Vitamin K antagonists and cancer: rebuttal.
S
S
Schulman
P
P
Lindmarker
D006801:Humans; D009369:Neoplasms / Q000517:prevention & control*; D018579:Patient Selection; D012107:Research Design; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000627:therapeutic use
D014812:Vitamin K; D014859:Warfarin